Sarepta Therapeutics (SRPT) P/FCF US GAAP (year values) |
|||||||||
2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
P/FCF | -18.3 | 526.1 | -15.2 | -31.9 | -15.1 | -15.8 | |||
Changes by years, y/y, % | +15% | -2 975% | -103% | +110% | -52% | -1.0% |
Sarepta Therapeutics. P/FCF
Sarepta Therapeutics. P/FCF, changes, %
Sarepta Therapeutics (SRPT) P/FCF US GAAP (quarter values) |
||||||||
2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
P/FCF | -17.5 | -15.3 | -18.6 | -28.3 | -25.3 | -15.8 | ||
Changes by years, y/y, % | -48% | -52% | -28% | +48% | +45% | |||
Changes by quarters, q/q, % | -8% | -12% | +21% | +52% | -11% |